Brief: Integra Lifesciences Q1 EPS USD 0.29
26/04/2023 11:12
Apr 26 (Reuters) - Integra Lifesciences Q1 EPS USD 0.29. * Q1 adjusted gross margin 67.3% * Q1 adjusted EPS USD 0.74 * Q1 adjusted net income USD 60.7 million * Q1 adjusted EBITDA USD 92.3 million * Q1 revenue USD 380.8 million
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes